Business
EKSO BIONICS HOLDINGS, INC.: BUSINESS Company Background Founded in 2005, we are a Nevada corporation that designs, develops, and markets exoskeleton products that augment human strength, endurance and mobility.
Net income decreased 3.2% to ($11.7M), while Operating cash flow decreased 19.9% to ($11.8M).
The read at a glance✓ Audited against SEC data
- Scale — FY2025 revenue N/AWatch
- Profitability — Net income ($11.7M)Watch
- Cash generation — Free cash flow ($12.0M)Note
- Accounting — No applicable forensic screenNote
- Insiders — 10 buys; 6 sells in 365 daysOK
- Capital — Comparable payout data unavailableNote
Where the revenue comes from
Fiscal 2025, as ChronoScale Corp reports it. History and quarterly detail are in the app.
- Product$9.2M
- Service$2.9M
- Subscription$358K
- Product and Service, Other$282K
Leadership changes
From ChronoScale Corp's own filings, the day they're filed.
- Andrew Cordell Schaap · Director · appointmenteff. 2026-06-29
Latest filings
- 8-K · Company announcement2026-08-27
- 10-K · Annual report2026-08-19
- 8-K · Company announcement2026-08-18
- 8-K · Company announcement2026-06-30
- 8-K · Company announcement2026-06-26
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about ChronoScale Corp, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.